1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial
    Journal Article

    Metzger-Filho, O.; Procter, M.; de Azambuja, E.; Leyland-Jones, B.; Gelber, R. D.; Dowsett, M.; Loi, S.; Saini, K. S.; Cameron, D.; Untch, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trial
    Journal Article

    Vose, J. M.; Carter, S.; Burns, L. J.; Ayala, E.; Press, O. W.; Moskowitz, C. H.; Stadtmauer, E. A.; Mineshi, S.; Ambinder, R.; Fenske, T.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Total marrow irradiation as part of autologous stem cell transplantation for Asian Patients with multiple myeloma
    Journal Article

    Lin, S. C.; Hsieh, P. Y.; Shueng, P. W.; Tien, H. J.; Wang, L. Y.; Hsieh, C. H.
    Biomed Research International (2013)

    Fulltext@MSK | Save
  • Randomized phase II trial of weekly vs. every 2 weeks vs. every 3 weeks nanoparticle albumin-bound paclitaxel with bevacizumab as first-line chemotherapy for metastatic breast cancer
    Journal Article

    Seidman, A. D.; Conlin, A. K.; Bach, A.; Moynahan, M. E.; Lake, D.; Forero, A.; Wright, G. S.; Hackney, M. H.; Clawson, A.; Norton, L.; more...
    Clinical Breast Cancer (2013)

    Fulltext@MSK | Save
  • Global, multicenter, randomized, phase ii trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
    Journal Article

    Wolpin, B. M.; O'Reilly, E. M.; Ko, Y. J.; Blaszkowsky, L. S.; Rarick, M.; Rocha Lima, C. M.; Ritch, P.; Chan, E.; Spratlin, J.; Macarulla, T.; more...
    Annals of Oncology (2013)

    Fulltext@MSK | Save
  • Pazopanib versus sunitinib in metastatic renal-cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Cella, D.; Reeves, J.; Hawkins, R.; Guo, J.; Nathan, P.; Staehler, M.; Souza, P.; Merchan, J. R.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer
    Journal Article

    Baselga, J.; Gomez, P.; Greil, R.; Braga, S.; Climent, M. A.; Wardley, A. M.; Kaufman, B.; Stemmer, S. M.; Pêgo, A.; Chan, A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Responding to a significant recruitment challenge within three nationwide psychoeducational trials for cancer patients
    Journal Article

    Stanton, A. L.; Morra, M. E.; Diefenbach, M. A.; Miller, S. M.; Perocchia, R. Slevin; Raich, P. C.; Fleisher, L.; Wen, K. Y.; Tran, Z. V.; Mohamed, N. E.; more...
    Journal of Cancer Survivorship (2013)

    Fulltext@MSK | Save
  • PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
    Journal Article

    Martin, M.; Prat, A.; Rodríguez-Lescure, A.; Caballero, R.; Ebbert, M. T. W.; Munárriz, B.; Ruiz-Borrego, M.; Bastien, R. R. L.; Crespo, C.; Davis, C.; more...
    Breast Cancer Research and Treatment (2013)

    Fulltext@MSK | Save
  • Selecting patients for acute normovolemic hemodilution during hepatic resection: A prospective randomized evaluation of nomogram-based allocation
    Journal Article

    Frankel, T. L.; Fischer, M.; Grant, F.; Krone, J.; D'Angelica, M. I.; DeMatteo, R. P.; Jarnagin, W. R.; Gonen, M.
    Journal of the American College of Surgeons (2013)

    Fulltext@MSK | Save